[Federal Register Volume 67, Number 69 (Wednesday, April 10, 2002)]
[Notices]
[Page 17468]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-8665]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 13, 2001, Cody 
Laboratories Inc., 331 33rd Street, Cody, Wyoming 82414, made 
application by letter to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
Hydromorphone (9150)......................  II
Fentanyl (9801)...........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances in 
bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than June 10, 2002.

    Dated: March 27, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-8665 Filed 4-9-02; 8:45 am]
BILLING CODE 4410-09-M